Sustained-Release Hydromorphone Microparticles Produced by Supercritical Fluid Polymer Encapsulation

Area of Science:

• Biomedical Engineering
• Drug Delivery Systems
• Pain Management

Background:

• Chronic cancer pain affects many patients, especially those with advanced disease.
• Current analgesic treatments have shown limited improvement over the past 30 years.
• Intractable cancer pain necessitates novel therapeutic strategies.

Purpose of the Study:

• To develop sustained-release poly(lactic-co-glycolic acid) microparticles of hydromorphone for intrathecal injection.
• To provide prolonged analgesia for patients suffering from intractable cancer-related pain.
• To offer a novel strategy for effective cancer pain management.

Main Methods:

• Utilized organic solvent-free supercritical fluid polymer encapsulation.
• Successfully produced hydromorphone-loaded microparticles.
• Characterized microparticles for size (20-45 μm), drug loading (9.2%), and encapsulation efficacy (92%).

Main Results:

• Achieved high drug loading and encapsulation efficacy.
• Produced microparticles within the desired size range for intrathecal injection.
• Demonstrated sustained drug release over a 5-week period in vitro.

Conclusions:

• Developed a promising sustained-release formulation of hydromorphone microparticles.
• The novel microparticle system shows potential for long-term intrathecal analgesia.
• This technology offers a new avenue for managing severe cancer-related pain.